In a study by Li et al., the efficacy of ginsenoside Ro (Gro) in modulating caspase-3 gene expression was demonstrated in APP/PS1 transgenic mice, an established AD model, as evidenced by Western blot analysis. This evidence concerns the gene APP and Alzheimer disease.